期刊文献+

环王巴明诱导DU145细胞凋亡的机制研究 被引量:1

Mechanism of cyclopamine induced apoptosis in human prostate cancer DU145 cell lines
下载PDF
导出
摘要 目的:研究环王巴明诱导DU145细胞凋亡作用及其对Gli-1和Bcl-2 mRNA表达的影响,探讨环王巴明诱导DU145细胞凋亡的机制。方法:不同浓度环王巴明处理DU145细胞后,吖啶橙染色,荧光显微镜下观察细胞形态变化。流式细胞术观察细胞凋亡率变化,RT-PCR检测5、10μmol/L环王巴明作用72h后的实验组和对照组Gli-1、Bcl-2 mRNA表达水平差异。结果:当环王巴明浓度大于5μmol/L作用72h后,荧光显微镜下可见细胞核固缩或碎裂,核仁变形等典型的凋亡形态学改变。环王巴明5μmol/L组Gli-1、Bcl-2mRNA表达减弱,但同对照组差异无统计学意义(P>0.05),与空白及DMSO对照组相比10μmol/L环王巴明可以显著下调Gli-1、Bcl-2 mRNA表达(P<0.01)。结论:环王巴明可诱导人前列腺癌DU145细胞株凋亡,其作用机制可能与下调Gli-1和Bcl-2mRNA表达,活化细胞凋亡的线粒体途径有关。 Objective:To investigate the effect of cyclopamine induce apoptosis to human prostate cancer cell line DUI45 ,and its impact on Gli - land Bcl -2 mRNA levels. Methods:To treat Du145 cells with cyclopamine at different concentration for 72h, and observe the morphology. Gli -1 and Bcl- 2 mRNA expression was examined by RT- PCR, and westemblot. Results : After cyclopamine of 5μmol/L treated for 72h, the nucleus pycnosis, fragmentation, chromatospherite disfiguration apoptotic morphology were observed in DU145 cells under fluorescence microscope. The expression levels of Gli - 1 and Bcl -2 mRNA in 5 μmol/L cyclopamine group were decreased but no statistical significance( P 〉0.05 ) ,While 10μmol/L cyclopamine group was down - regulated significantly compare with control and DMSO group( P 〈 0.01 ). Conclusion:The mechanism of cyclopamine induced apoptosis in DUI45 cell lines may be related to down- regulation of expression levels of Gli- 1 and Bcl-2 mRNA,and active the mitochondrial apoptotic pathways.
出处 《现代肿瘤医学》 CAS 2010年第7期1267-1270,共4页 Journal of Modern Oncology
基金 甘肃省兰州市自然科学基金资助项目(编号:07-1-81)
关键词 环王巴明 前列腺癌 DU145细胞 凋亡 cyclopamine prostate cancer DU145 cell apoptosis
  • 相关文献

参考文献18

  • 1Jemal A,Tiwari RC,Murray T,et al.Cancer statistics[J].CA Cancer J Clin,2004,54(1):8-29.
  • 2Mimeault M,Batra SK.Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies[J].Carcinogenesis,2006,27 (1):1-22.
  • 3Winquist E,Waldron T,Berry S,et al.Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases:a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group[J].BMC Cancer,2006,6:112.
  • 4Berry W,Eisenberger M.Achieving treatment goals for hormone -refractory prostate cancer with chemotherapy[J].Oncologist,2005,10(Suppl 3):30-39.
  • 5Arlen PM,Gulley JL.Docetaxel-based regimens,the standard of care for metastatic androgen-insensitive prostate cancer[J].Future Oncol,2005,1 (1):19-22.
  • 6Di Lorenzo G,De Placido S.Hormone refractory prostate cancer (HRPC):present and future approaches of therapy[J].Int J Immunapathol Pharmacol,2006,19 (1):11-34.
  • 7Mimeault M,Batra SK.Concise review:recent advances on the significance of stem cells in tissue regeneration and cancer therapies[J].Stem Cells,2006,24(11):2319-2345.
  • 8Karhadkar SS,Bova GS,Abdallah N,et al.Hedgehog signalling in prostae regeneration,neoplasia and metastasis[J].Nature,2004,431 (7009):707-712.
  • 9Mimeault M,Moore E,Moniaux N,et al.Cytotoxic effects induced by a combination of cyclopamine and gefitinib,the selective hedgehog and epidermal growth factor receptor signaling inhibitors,in prostate cancer cells[J].Int J Cancer,2006,118 (4):1022-1031.
  • 10Ruizi Altaba A,Sánchez P,Dahmane N.Gli and hedgehog in cancer:tumours,embryos aad stem cells[J].Nat Rev Cancer,2002,2(5):361-372.

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部